PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.94
ESG score 90-95% of TGTX's 60.42. Bill Ackman would demand clear ESG improvement catalysts.
54.17
Environmental score 80-90% of TGTX's 60.36. Walter Schloss would scrutinize carbon exposure and transition planning.
56.72
Social score 80-90% of TGTX's 63.70. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
56.94
Similar governance score to TGTX's 57.19. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.